Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Advanced Proteome Therapeutics Corporation Regulatory Filings 2023

Jan 12, 2023

45936_rns_2023-01-12_fc1b25d1-b1a6-4525-b51a-7b2528cc643e.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Via SEDAR

Advanced Proteome Therapeutics Corporation

January 12, 2023

TO ALL REGULATORS AND EXCHANGES

RE: Advanced Proteome Therapeutics Corporation (the "Issuer") Notice of Meeting and Record Dates - Amended

We advise the following with respect to the Issuer's upcoming Meeting of Security Holders:

1 Meeting Type Annual & Special Meeting
2 Record Date for Notice of Meeting December 27, 2022
3 Record Date for Voting (If Applicable) December 27, 2022
4 Beneficial Ownership Determination Date December 27, 2022
5 Meeting Date February 22, 2023 - Amended
6 Meeting Location 104 - 8337 Eastlake Drive, Burnaby
British Columbia, V5A 4W2
7 Voting Securities Details
8 Description (Class) Common
9 ISIN / CUSIP CA0076282098 / 007628209
10 Issuer sending proxy related materials directly to Non-Objecting Beneficial Owners (NOBOs) No
11 Issuer paying for mailing to Objecting Beneficial Owners (OBOs) No
12 Notice and Access
Beneficial Holders No
Registered Holders No
13 Material Selection S - All & Special Materials

Regards,

/s/ "Paul Woodward"

Paul Woodward, CEO

Advanced Proteome Therapeutics Corporation